Clinical significance of serum follistatin levels in the diagnosis of ovarian endometrioma and benign ovarian cysts
| Autor: | Hasan Onur Topçu, Cavkaytar S, Ali İrfan Güzel, Metin Kaba, Gülnur Özakşit, Omer Ant |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2015 |
| Předmět: |
Adult
endometriosis medicine.medical_specialty endocrine system Adolescent CA-19-9 Antigen Memory Episodic Endometriosis Benign Ovarian Cyst Gastroenterology lcsh:Gynecology and obstetrics Young Adult Internal medicine Obstetrics and Gynaecology medicine follistatin Humans Clinical significance Ovarian Diseases CA-125 Prospective cohort study lcsh:RG1-991 Gynecology Ovarian Endometrioma biology business.industry diagnostic marker Obstetrics and Gynecology medicine.disease Ovarian Cysts ROC Curve CA-125 Antigen CA 19-9 biology.protein Female Laparoscopy CA19-9 business Body mass index hormones hormone substitutes and hormone antagonists Follistatin |
| Zdroj: | Taiwanese Journal of Obstetrics & Gynecology, Vol 54, Iss 3, Pp 236-239 (2015) |
| ISSN: | 1028-4559 |
| Popis: | Objective: To determine the clinical significance of serum follistatin levels in women with an ovarian endometrioma. Materials and methods: This is a prospective study of 89 women, 56 with an ovarian endometrioma (endometrioma group) and 33 with a benign ovarian cyst (control group) who underwent laparoscopic excision. Age, parity, body mass index, serum CA-125, serum CA 19-9, and serum follistatin levels were determined for all participants and evaluated as potential prognostic factors prior to laparoscopic cystectomy. Results: There were no significant differences in demographic factors between the endometrioma group and the control group. However, serum follistatin levels were significantly higher in the endometrioma group (9350 ± 895 pg/mL vs. control group 725 ± 72 pg/mL, p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|